ifosfamide has been researched along with Dysuria in 2 studies
Dysuria: Painful URINATION. It is often associated with infections of the lower URINARY TRACT.
Excerpt | Relevance | Reference |
---|---|---|
"Pancreatic Ewing's sarcoma is not reported commonly, with inconsistent clinical manifestations." | 1.72 | Rare presentation in a rare case of pancreatic extraosseous Ewing's sarcoma: A case report. ( Chan, WT; Hou, JY; Jiang, CB; Lee, HC; Liu, HC; Liu, YC; Sheu, JC; Wu, PS; Yeh, TC; Yeung, CY, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Liu, YC | 3 |
Yeh, TC | 3 |
Wu, PS | 3 |
Sheu, JC | 3 |
Lee, HC | 3 |
Yeung, CY | 3 |
Jiang, CB | 3 |
Liu, HC | 3 |
Hou, JY | 3 |
Chan, WT | 3 |
Yamamoto, Y | 1 |
Tsukiyama, I | 1 |
Nii, S | 1 |
Harada, R | 1 |
Watanabe, K | 1 |
Yabushita, H | 1 |
Wakatsuki, A | 1 |
Saito, H | 1 |
Hasegawa, T | 1 |
2 other studies available for ifosfamide and Dysuria
Article | Year |
---|---|
Rare presentation in a rare case of pancreatic extraosseous Ewing's sarcoma: A case report.
Topics: Adolescent; Cyclophosphamide; Dysuria; Epirubicin; Etoposide; Flank Pain; Humans; Ifosfamide; Male; | 2022 |
Rare presentation in a rare case of pancreatic extraosseous Ewing's sarcoma: A case report.
Topics: Adolescent; Cyclophosphamide; Dysuria; Epirubicin; Etoposide; Flank Pain; Humans; Ifosfamide; Male; | 2022 |
Rare presentation in a rare case of pancreatic extraosseous Ewing's sarcoma: A case report.
Topics: Adolescent; Cyclophosphamide; Dysuria; Epirubicin; Etoposide; Flank Pain; Humans; Ifosfamide; Male; | 2022 |
Rare presentation in a rare case of pancreatic extraosseous Ewing's sarcoma: A case report.
Topics: Adolescent; Cyclophosphamide; Dysuria; Epirubicin; Etoposide; Flank Pain; Humans; Ifosfamide; Male; | 2022 |
[A case of Ifosfamide-induced dysuria which could be avoided by changing the regimen of mesna].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Dysuria; Female; Humans; Ifosfamid | 2013 |